APA (7th ed.) Citation

A, P., F, D. C., D, B., & A, C. (2025). Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation. The journal of pain, 33, 105456. https://doi.org/10.1016/j.jpain.2025.105456

Chicago Style (17th ed.) Citation

A, Pistolesi, De Cesaris F, Buonvicino D, and Chiarugi A. "Reduction of Opioid Withdrawal Symptoms and Opioid-induced Hyperalgesia by Subcutaneous Sumatriptan Reveals Central Neuromodulation." The Journal of Pain 33 (2025): 105456. https://doi.org/10.1016/j.jpain.2025.105456.

MLA (9th ed.) Citation

A, Pistolesi, et al. "Reduction of Opioid Withdrawal Symptoms and Opioid-induced Hyperalgesia by Subcutaneous Sumatriptan Reveals Central Neuromodulation." The Journal of Pain, vol. 33, 2025, p. 105456, https://doi.org/10.1016/j.jpain.2025.105456.